Erschienen in:
01.04.2011 | Mitochondrial Medicine
Altering the balance between healthy and mutated mitochondrial DNA
verfasst von:
Paul M. Smith, Robert N. Lightowlers
Erschienen in:
Journal of Inherited Metabolic Disease
|
Ausgabe 2/2011
Einloggen, um Zugang zu erhalten
Abstract
Pathogenic mutations of the mitochondrial genome are frequently found to co-exist with wild-type mtDNA molecules, a state known as heteroplasmy. In most disease cases, the mutation is recessive with manifestation of a clinical phenotype occurring when the proportion of mutated mtDNA exceeds a high threshold. The concept of increasing the ratio of healthy to mutated mtDNA as a means to correcting the biochemical defect has received much attention. A number of strategies are highlighted in this article, including manipulation of the mitochondrial genome by antigenomic drugs or restriction endonucleases, zinc finger peptide-targeted nucleases and exercise-induced gene shifting. The feasibility of these approaches has been demonstrated in a number of models, however more work is necessary before use in human patients.